Addus HomeCare (NASDAQ:ADUS) Releases Quarterly Earnings Results

Addus HomeCare (NASDAQ:ADUS) released its quarterly earnings results on Monday. The company reported $1.35 EPS for the quarter, beating the consensus estimate of $1.21 by $0.14, Briefing.com reports. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. The business had revenue of $286.90 million for the quarter, compared to analyst estimates of $284.90 million. During the same period in the prior year, the business earned $0.94 earnings per share. The company’s quarterly revenue was up 10.4% on a year-over-year basis.

Addus HomeCare Trading Down 2.5 %

Shares of NASDAQ ADUS traded down $3.16 during trading on Wednesday, hitting $121.34. 73,613 shares of the company traded hands, compared to its average volume of 136,372. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.14. The firm has a market capitalization of $2.20 billion, a P/E ratio of 30.89, a P/E/G ratio of 2.35 and a beta of 1.01. The company has a 50-day moving average price of $118.43 and a 200-day moving average price of $105.29. Addus HomeCare has a 1 year low of $78.35 and a 1 year high of $126.70.

Wall Street Analyst Weigh In

ADUS has been the topic of a number of analyst reports. StockNews.com lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 7th. Macquarie started coverage on shares of Addus HomeCare in a report on Friday, June 28th. They set an “outperform” rating and a $136.00 price target for the company. Stephens reissued an “overweight” rating and issued a $138.00 price objective on shares of Addus HomeCare in a research report on Tuesday. Barclays lowered shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 target price on the stock. in a research report on Tuesday, April 23rd. Finally, Bank of America boosted their price target on Addus HomeCare from $115.00 to $118.00 and gave the company a “buy” rating in a report on Tuesday, May 7th. One investment analyst has rated the stock with a sell rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $120.71.

Insider Buying and Selling

In other news, EVP Roberton James Stevenson sold 217 shares of Addus HomeCare stock in a transaction dated Monday, June 17th. The stock was sold at an average price of $116.13, for a total value of $25,200.21. Following the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at approximately $1,186,500.21. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 4.60% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.